Home

FARMACEUTICA LDA DEFIANTE

CIK 1168857 · last filed 2012-05-02

FARMACEUTICA LDA DEFIANTE is a corporate insider who has filed 12 SEC Form 4 insider transactions across 1 company since 2007. The most recent filing, for SCLN, was dated May 2, 2012. Across all open-market trades the lifetime net is −$65.0M, making them a net seller over the disclosed history. 49 SEC filings were submitted jointly with SPA Essetifin.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

12

Lifetime Open-Market Net

-$65.01M

Filer Profile

Reported Address
RUA DOS FERREIROS,260
FUNCHAL MADEIRA, S1 9000-082
Formerly Known As
DEFIANTE FARMACEUTICA UNIPESSOAL LDA (2002–2003)
Related Filers
SPA Essetifin — 49 joint filings, latest 2012-05-02
S P A APTAFIN — 11 joint filings, latest 2007-11-23
CLAUDIO CAVAZZA — 11 joint filings, latest 2007-11-23
PAOLO CAVAZZA — 11 joint filings, latest 2007-11-23
Consultadoria & Servicos SDC Unipessoal LDA Chaumiere — 2 joint filings, latest 2007-11-23
Consultadoria & Servicos L.D.A. Inverlochy — 2 joint filings, latest 2007-11-23
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SCICLONE PHARMACEUTICALS INC (SCLN) Delisted 10%+ Owner 0 — — -$65.01M 11 2012-05-02

Recent Filings

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2012-05-02 SCICLONE PHARMACEUTICALS INC (SCLN) Delisted Mixed −13,161,876 -$69.10M EDGAR
2011-01-07 — Mixed +1,851,852 $500.0K
2008-02-01 SCICLONE PHARMACEUTICALS INC (SCLN) Delisted Buy (P) +57,200 $117.2K EDGAR
2008-01-28 SCICLONE PHARMACEUTICALS INC (SCLN) Delisted Buy (P) +72,574 $148.4K EDGAR
2008-01-24 SCICLONE PHARMACEUTICALS INC (SCLN) Delisted Buy (P) +58,266 $117.3K EDGAR
2008-01-24 SCICLONE PHARMACEUTICALS INC (SCLN) Delisted Buy (P) +400 $800 EDGAR
2008-01-17 SCICLONE PHARMACEUTICALS INC (SCLN) Delisted Buy (P) +126,658 $255.1K EDGAR
2008-01-15 SCICLONE PHARMACEUTICALS INC (SCLN) Delisted Buy (P) +56,802 $113.6K EDGAR
2007-11-09 SCICLONE PHARMACEUTICALS INC (SCLN) Delisted Buy (P) +34,714 $71.1K EDGAR
2007-11-05 SCICLONE PHARMACEUTICALS INC (SCLN) Delisted Buy (P) +108,238 $221.8K EDGAR
Showing 1–10 of 12
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.